Results 171 to 180 of about 10,531,467 (204)
Some of the next articles are maybe not open access.
Long‐Term Outcome of Ustekinumab Therapy for Behçet's Disease
Arthritis & Rheumatology, 2019Oral ulcers, the hallmark lesion of Behçet's disease (BD), can be disabling and resistant to conventional treatment, and there is a need for safe and effective treatment.
A. Mirouse +9 more
semanticscholar +1 more source
Journal Francais d'Ophtalmologie, 2019
Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries.
Imen Khairallah Ksiaa +7 more
semanticscholar +1 more source
Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries.
Imen Khairallah Ksiaa +7 more
semanticscholar +1 more source
Behçet's disease: New insights into pathophysiology, clinical features and treatment options.
Autoimmunity Reviews, 2018Behçet's disease (BD) is a rare systemic vasculitis characterized by oral aphthous ulcers, genital ulcers, ocular lesions and other systemic manifestations.
A. Greco +7 more
semanticscholar +1 more source
Gastrointestinal Involvement in Behçet Disease.
Rheumatic Disease Clinics of North America, 2018I. Hatemi, G. Hatemi, A. Çelik
semanticscholar +1 more source
Journal of the European Academy of Dermatology and Venereology, 2017
E. Şenel, Emre Demir, R. M. Alkan
semanticscholar +1 more source
E. Şenel, Emre Demir, R. M. Alkan
semanticscholar +1 more source
'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
Nature Reviews Rheumatology, 2015D. McGonagle +4 more
semanticscholar +1 more source